Formation of proteoglycan and collagen-rich scaffold-free stiff cartilaginous tissue using two-step culture methods with combinations of growth factors.
Tissue-engineered cartilage may be expected to serve as an alternative to autologous chondrocyte transplantation treatment. Several methods for producing cartilaginous tissue have been reported. In this study, we describe the production of scaffold-free stiff cartilaginous tissue of pig and human, using allogeneic serum and growth factors. The tissue was formed in a mold using chondrocytes recovered from alginate bead culture and maintained in a medium with transforming growth factor-beta and several other additives. In the case of porcine tissue, the tear strength of the tissue and the contents of proteoglycan (PG) and collagen per unit of DNA increased dose-dependently with transforming growth factor-beta. The length of culture was significantly and positively correlated with thickness, tear strength, and PG and collagen contents. Tear strength showed positive high correlations with both PG and collagen contents. A positive correlation was also seen between PG content and collagen content. Similar results were obtained with human cartilaginous tissue formed from chondrocytes expanded in monolayer culture. Further, an in vivo pilot study using pig articular cartilage defect model demonstrated that the cartilaginous tissue was well integrated with surrounding tissue at 13 weeks after the implantation. In conclusion, we successfully produced implantable scaffold-free stiff cartilaginous tissue, which characterized high PG and collagen contents.
Miyazaki
Tatsuya
T
Division of Research Institute, PG Research Co. Ltd., 4-13-11 Hanakoganei, Kodaira, Tokyo 187-0002, Japan. tatsumiyazaki@aol.com
Miyauchi
Satoshi
S
Matsuzaka
Satoshi
S
Yamagishi
Chie
C
Kobayashi
Kohei
K
D000368:Aged; D000369:Aged, 80 and over; D000818:Animals; D002356:Cartilage / Q000187:drug effects / Q000502:physiology*; D003094:Collagen / Q000378:metabolism*; D005260:Female; D006801:Humans; D036341:Intercellular Signaling Peptides and Proteins / Q000494:pharmacology*; D008422:Materials Testing; D055595:Mechanical Phenomena / Q000187:drug effects; D008875:Middle Aged; D023421:Models, Animal; D011509:Proteoglycans / Q000096:biosynthesis*; D034421:Sus scrofa; D046509:Tissue Culture Techniques / Q000379:methods*; D023822:Tissue Engineering / Q000379:methods*; D054457:Tissue Scaffolds / Q000737:chemistry*
D036341:Intercellular Signaling Peptides and Proteins; D011509:Proteoglycans; D003094:Collagen